The “Spot Sign”: A predictor of hematoma expansion
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INTRODUCTION

CASE PRESENTATION

DISCUSSION/CONCLUSION

In this poster, we show the utility of the CT Angiogram (CTA) “Spot
sign” as a predictor of intracranial hematoma expansion and
subsequent neurologic decline, and demonstrate the measures we
utilized to decrease the morbidity and mortality of the patient in this
case report. We discuss the hospital course of a 69-year-old male
who presented with hypertensive emergency and focal neurologic
deficits and was found to have a large basal ganglia hypertensive
bleed with “Spot sign” present on CTA head and neck with and
without contrast. Patient was treated very aggressively and was
given hypertonic solutions due to the team’s quick recognition of the
“Spot sign” signaling potential for future hematoma expansion.
Though as predicted by the “Spot sign”, his bleed did expand, the
patient survived with our aggressive measures at the onset of bleed.

This is a 68-year-old right-handed Caucasian male with no known
prior medical history other than alcohol abuse who presented
secondary to a sudden onset of left sided weakness while sitting on
a barstool. Patient fell to the ground, did not lose consciousness, and
came in for potential large vessel occlusion. On the initial stat CT
head without contrast, the patient was noted to have a large right
supra-tentorial 6.4 x 3.1 cm hemorrhage (Image A). On arrival, the
patient was noted to be hypertensive with systolic blood pressure as
high as 195. A CTA head and neck with and without contrast was
ordered which demonstrated that he did not have evidence of
vascular malformation but did have evidence of large blush of
contrast within the hematoma consistent with active hemorrhage
(Image B). At this time the patient was started on hypertonic
solutions in the form of 3% hypertonic saline in an urgent fashion.
Repeat CT head demonstrated a mild interval increase in the size of
the right basal ganglia hemorrhage with intraventricular extension
(Image C). With serial CT head imaging without contrast, the
hemorrhage remained stable, and the hypertonic saline was
eventually discontinued. His hospital course was complicated by
delirium tremens in the setting of daily alcoholism, for which he was
also treated for and subsequently required intubation and eventual
peg and trach placement. Further neurologic workup including EEGs
were unremarkable for epileptiform discharges. He continued to
remain stable from a neurological standpoint. Patient was able to be
discharged from the hospital to a long-term acute care facility with
clear instructions for repeat CT head imaging to be done as an
outpatient.

The CTA “Spot sign” in intracranial hemorrhage has been shown to
be a reliable imaging sign for determining hematoma expansion (8).
This sign is an important predictor for pending neurologic decline
secondary to hemorrhagic expansion and is an indicator for patients
who may have improved outcomes with aggressive and immediate
interventions to avoid significant morbidity and mortality (4). One
such intervention is for craniotomy with hematoma removal which
can lead to an improved prognosis in “Spot sign” positive patients
(9).

BACKGROUND
The “Spot sign” is a radiographic sign that can be found on a CTA
study and represents a spot of active extraluminal extravasation and
accumulation of contrast dye within an intracerebral hemorrhage (1,
2). Theoretically, the sign has been seen in shape as linear, branching
or spherical (3). When this sign is identified on imaging, it indicates
an increased likelihood of significant increase in size of hematoma
expansion, as this sign is an independent predictor of growth and
poor outcomes (4). Meta-analysis studies have shown that, "for each
10% increase in hematoma volume, patients were 5% more likely to
die and 16% more likely to increase one point on the modified rankin
scale" (5). However, if identified correctly the “Spot sign” can be
utilized to identify patients who are most likely to benefit from
medical and surgical therapy for rapid expansion of intracranial
hematoma (6, 7). The “Spot sign” serves as a predictor for possible
hematoma expansion and warrants close neurologic monitoring.
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It is important to recognize patients with intracranial hemorrhage
and have CTA performed as soon as possible as it has been shown
that the longer it takes for the patient to get the CTA, the more the
positive predictive value of the “Spot sign” decreases (10). In fact,
CTA followed by 90 second delayed post-contrast CT, also known as a
“delayed CTA”, is a further predictor of the amount of hematoma
expansion based on the amount of contrast extravasation, showing
that the “Spot sign” can measure active bleeding in these patients
which can help better select patients who may see a benefit from
additional therapies (6, 7). There is also importance to the timing of
the CTA, as when the “Spot sign” was seen arterial and therefore
earlier in the imaging, there was greater expansion of the
hemorrhage while the later or venous images improved the
detection of “Spot signs” (11).
We present the importance of recognizing the “Spot sign” to help
alert clinicians to the utility of this important diagnostic tool. This is a
clear sign of impending hematoma expansion and prompt
recognition is required to guide prognosis and management to
decrease the morbidity and mortality otherwise expected from a
rapidly expanding bleed. In our presented case, the quick actions of
the team in recognizing the “Spot sign” and beginning 3% hypertonic
saline early led to only mild interval increase in the size of the right
basal ganglia hemorrhage with some intraventricular extension as
opposed to the catastrophic possibilities that the “Spot sign”
signifies.
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Image A. Initial CT head
without contrast
demonstrating right basal
ganglia hemorrhage

Image B. The initial CTA
head and neck with contrast
demonstrating large blush of
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Image C. Repeat CT head
without contrast
demonstrating worsening of
right basal ganglia
hematoma with
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